HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Nakagami Selected Research

3- (2- (2- phenyl- 4- (4- pyridin- 4- ylbenzyl)morpholin- 2- yl)ethyl)quinazoline- 2,4(1H,3H)- dione

12/2009Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Nakagami Research Topics

Disease

6Alzheimer Disease (Alzheimer's Disease)
12/2004 - 02/2002
5Amyloid Plaque
12/2004 - 02/2002
3Inflammation (Inflammations)
03/2015 - 08/2008
2Choroidal Neovascularization
07/2019 - 01/2019
2Chronic Renal Insufficiency
01/2016 - 03/2015
2Atopic Dermatitis (Atopic Eczema)
10/2010 - 12/2009
2Asthma (Bronchial Asthma)
01/2010 - 08/2008
2Hypersensitivity (Allergy)
08/2008 - 03/2005
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2020
1Retinal Neovascularization
01/2019
1Dermatitis
09/2016
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2016
1Pulmonary Arterial Hypertension
01/2016
1Mitochondrial Myopathies (Mitochondrial Myopathy)
01/2016
1Necrosis
10/2010
1Shock
10/2010
1Metaplasia
10/2009
1Virus Diseases (Viral Diseases)
08/2008
1Infections
08/2008
1Common Cold
08/2008
1Allergic Rhinitis
03/2005
1Sneezing
03/2005
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2004

Drug/Important Bio-Agent (IBA)

6Amyloid beta-PeptidesIBA
12/2004 - 02/2002
3AllergensIBA
10/2009 - 03/2005
2bardoxolone methylIBA
01/2016 - 03/2015
2CCR4 ReceptorsIBA
10/2010 - 01/2010
2OvalbuminIBA
10/2010 - 01/2010
26- ethyl- N,N'- bis(3- hydroxyphenyl)(1,3,5)triazine- 2,4- diamineIBA
12/2003 - 12/2002
1Scopolamine (Hyoscine)FDA Link
01/2020
1AntibodiesIBA
07/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2019
1Tight Junction ProteinsIBA
01/2019
1omaveloxoloneIBA
09/2016
1Rhodopsin (Visual Purple)IBA
01/2016
1AlbuminsIBA
03/2015
1Oxygen (Dioxygen)IBA
03/2015
1RS-1269IBA
10/2010
1LipopolysaccharidesIBA
10/2010
12- (4- (2- (diethylamino)ethoxy)phenyl)- N- (2,4- difluorobenzyl)- 5- fluoropyrimidin- 4- amineIBA
01/2010
13- (2- (2- phenyl- 4- (4- pyridin- 4- ylbenzyl)morpholin- 2- yl)ethyl)quinazoline- 2,4(1H,3H)- dioneIBA
12/2009
1Transcription Factors (Transcription Factor)IBA
10/2009
1gamma-AIBA
08/2008
1CytokinesIBA
08/2008
1Messenger RNA (mRNA)IBA
08/2008
1AnionsIBA
08/2008
1Histamine (Histamine Dihydrochloride)FDA Link
03/2005
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
03/2005
1P2-246-259IBA
03/2005
1Nerve Growth Factors (Neurotrophins)IBA
12/2004
1Neuroprotective AgentsIBA
12/2003
1Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2003
14- (7- hydroxy- 2,2,4- trimethyl- chroman- 4- yl)benzene- 1,3- diolIBA
07/2003
1Proteins (Proteins, Gene)FDA Link
12/2002
1Peptides (Polypeptides)IBA
12/2002

Therapy/Procedure

2Lasers (Laser)
07/2019 - 01/2019
2Oral Administration
10/2010 - 03/2005